Category : INTENSE-TBM | Date : Juil 5, 2021

INTENSE-TBM 4th General Assembly

On 5 July 2021, the 4th General Assembly of the INTENSE-TBM project was held virtually. Led by the project coordinator Professor Fabrice Bonnet, it brought together 34 participants, including 4 international external experts and our EDCTP Project Officer (Shingai Machingaidze) for a fruitful discussion about protocol, SOPs, sub-studies…but also administrative issues.

It was also the opportunity to discuss a major milestone of the project, i.e the start of the inclusions in the trial in Madagascar (February 2021), Côte d’Ivoire (February 2021) and South Africa (April 2021), soon to be joined by Uganda.

See also the article in the EDCTP Newsletter: here.
The General Assembly is the decisional body of the Projet. It makes sure that the Project is implemented properly according to the initial Project Plan, not only scientifically but also clinically
and ethically, and taking into account the required adjustments when need be.
It ensures the correct implementation of the Project and compliance with the protocol and the Standard Operational Procedure of the Sponsor. It identifies strategic opportunities in a timeline shaping the scientific side of the Project.
It keeps contact with the Data and Safety Monitoring Board (DSMB) and will make sure that investigators and other trial personnel have access to up‐to‐date information.